-
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized TrialG Lemesle, M Laine, M Pankert et al. -
Characterization of lesions undergoing ischemia-driven revascularization after complete revascularization versus culprit lesion only in patients with STEMI and multivessel disease - A DANAMI-3-PRIMULTI substudyDe Backer O, Lønborg J, Helqvist S et al.
-
Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial InfarctionKH Cho , XY Han, and on behalf of the KAMIR-NIH Investigators.
-
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACSY Kobayashi, J Lønborg, DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI Study Investigators
-
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary InterventionP Tricoci, LK Newby et al.
-
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementPB Shah, FGP Welt, E Mahmud et al.
-
Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized TrialsElgendy IY, Mahmoud AN, Kumbhani DJ et al.
-
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialValgimigli M, Frigoli E, MATRIX Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
